A comprehensive analysis of different gene classes in pancreatic cancer: SIGLEC15 may be a promising immunotherapeutic target
Crossref DOI link: https://doi.org/10.1007/s10637-021-01176-5
Published Online: 2021-09-13
Published Print: 2022-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xu, Ji-li
Guo, Yong http://orcid.org/0000-0002-0202-3359
Text and Data Mining valid from 2021-09-13
Version of Record valid from 2021-09-13
Article History
Received: 16 August 2021
Accepted: 2 September 2021
First Online: 13 September 2021
Declarations
:
: Not applicable.